pirfenidone news

All news on pirfenidone (also known as Esbriet): plants, production capacities, investments and involved companies.

17 July 2026

Boehringer Ingelheim: EU approval for JASCAYD (nerandomilast) in IPF and PPF

First-in-class oral PDE4B inhibitor approved for adults with IPF and PPF after Phase III trials showed slower lung function decline and a favourable tolerability profile.

Who will be producing pirfenidone in the future?

Find out with chemXplore Alpha

Learn more